
Alembic Pharma shares gain after drugmaker gets USFDA approval for cancer treatment drug
With this approval, Alembic Pharma now has a cumulative total of 236 ANDA approvals from the USFDA, including 218 final approvals and 18 tentative approvals.

With this approval, Alembic Pharma now has a cumulative total of 236 ANDA approvals from the USFDA, including 218 final approvals and 18 tentative approvals.

The brokerage said that around 200 Zudio store additions in FY26 provide healthy visibility for FY27, despite some moderation in store productivity.

Prashant Jain, Founder & CIO of 3P Investment Managers, is more comfortable with largecaps. He believes small and midcaps have run ahead of fundamentals over…

Under the agreement, Signature Global has signed a licensing arrangement to brand the development as “Tonino Lamborghini Residences Gurugram”, with the Italian brand’s design philosophy…

Manoj Gori, Associate Director, Equities at Equirus Securities, said room AC demand has picked up in southern markets. While diversified appliance companies offer long-term exposure,…

While timelines for commercial finalisation and execution risks remain key monitorables, Citi sees this development as a medium-term positive for HAL.

Emkay wrote in its note on Thursday that there will be a mega shift towards electrification in the automobiles segment and this shift is likely…

Rupee edges up to 93.28 per dollar as Iran ceasefire hopes lift sentiment, but importer dollar demand and narrow volatility keep gains capped.

The total market capitalisation of companies listed in Taiwan reached about $4.14 trillion as of Wednesday, edging past the UK’s roughly $4.09 trillion.

Drew Pettit said a rebound in equities driven by repositioning as geopolitical concerns ease, while noting that earnings growth may remain concentrated in select sectors.…